Article
Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer
2020-12-15
Abstract excerpt
<h4>Background: </h4> KRAS is the most frequently mutated oncogene in cancer, however efforts to develop targeted therapies have been largely unsuccessful. Recently, two small-molecule inhibitors, AMG 510 and MRTX849, have shown promising activity in KRAS G12C-mutant solid tumors. The current study aims to assess the molecular profile of KRAS G12C in colorectal (CRC) and non-small-cell lung cancer (NSCLC) tested i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1e5664ee-fc3c-5224-bdc2-725212c22d4e
- DOI
- 10.21203/rs.3.rs-108171/v1
